Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Rheumatology

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis: A nationwide cohort study from the DANBIO and DERMBIO registries

Seminars in Arthritis and Rheumatism | Feb 15, 2022 Rheumatology

Obesity and response to advanced therapies in rheumatoid arthritis

Arthritis Care & Research | Feb 15, 2022 Rheumatology

Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis

Annals of Rheumatic Diseases | Feb 12, 2022 Rheumatology

Phase II randomized trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

Annals of Rheumatic Diseases | Feb 12, 2022 Rheumatology

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: A meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

Osteoporosis International | Feb 11, 2022 Rheumatology

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

International Journal of Rheumatic Diseases | Feb 11, 2022 Rheumatology

Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US

JAMA | Feb 10, 2022 Rheumatology

Post-vaccination antibody titers predict protection against COVID-19 in patients with autoimmune diseases: Survival analysis in a prospective cohort

Annals of Rheumatic Diseases | Feb 10, 2022 Rheumatology

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States

Lupus | Feb 09, 2022 Rheumatology

Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes

Lupus | Feb 08, 2022 Rheumatology

« Prev 1 2 3 4 5 … 118 Next »

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis: A nationwide cohort study from the DANBIO and DERMBIO registries

Obesity and response to advanced therapies in rheumatoid arthritis

Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis

Phase II randomized trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: A meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US

Post-vaccination antibody titers predict protection against COVID-19 in patients with autoimmune diseases: Survival analysis in a prospective cohort

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States

Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis: A nationwide cohort study from the DANBIO and DERMBIO registries

Obesity and response to advanced therapies in rheumatoid arthritis

Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis

Phase II randomized trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: A meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

Long‐term outcome of patients with palindromic rheumatism treated with methotrexate

Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US

Post-vaccination antibody titers predict protection against COVID-19 in patients with autoimmune diseases: Survival analysis in a prospective cohort

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States

Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic